Please use this identifier to cite or link to this item:
https://swslhd.intersearch.com.au/swslhdjspui/handle/1/12918
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Katsoudas, N. | - |
dc.contributor.author | Tavakoli, P. | - |
dc.contributor.author | Wu, N. | - |
dc.contributor.author | Shapiro, A. | - |
dc.contributor.author | Leach, S. T. | - |
dc.contributor.author | Williams, A. J. | - |
dc.contributor.author | Paramsothy, R. | - |
dc.contributor.author | Ghaly, S. | - |
dc.contributor.author | Connor, S. J. | - |
dc.contributor.author | Samocha-Bonet, D. | - |
dc.contributor.author | Lambert, K. | - |
dc.contributor.author | Hold, G. L. | - |
dc.date.accessioned | 2024-09-02T05:56:38Z | - |
dc.date.available | 2024-09-02T05:56:38Z | - |
dc.date.issued | 2024 | - |
dc.identifier.issn | 10780998 (ISSN) | - |
dc.identifier.uri | https://swslhd.intersearch.com.au/swslhdjspui/handle/1/12918 | - |
dc.description.abstract | Background: Emulsifiers are implicated in the pathogenesis of inflammatory bowel disease (IBD). Few studies have examined emulsifier intake in people with existing IBD. We aimed to describe the frequency of exposure to 6 selected emulsifiers in a contemporary cohort of people with IBD and compare intake with healthy controls (HCs). Methods: Baseline food records from participants in an Australian prospective cohort study examining the microbiome of IBD patients and HCs were analyzed. Exposure to inflammatory emulsifiers polysorbate-80 (P80); carboxymethylcellulose (CMC); carrageenan; xanthan gum (XG); lecithin (soy and sunflower) and mono- and diglycerides of fatty acids (MDGs) were determined by examining ingredient lists. Frequency of emulsifier exposure between groups (IBD vs HC, Crohn's disease [CD] vs ulcerative colitis [UC], IBD children vs adults, active disease vs remission) was examined after controlling for confounders. Results: Records from 367 participants were analyzed (n = 176 IBD, of which there were 101 CD, 75 UC, and 191 HC patients). In total, 5022 unique food items were examined, with 18% containing 1 or more emulsifier of interest. Inflammatory bowel disease participants had significantly higher total daily emulsifier exposure compared with HCs (2.7 ± 1.8 vs 2.3 ± 1.6, P = .02). In IBD participants, emulsifiers with the highest daily exposure were MDGs (1.2 ± 0.93), lecithin (0.85 ± 0.93), and XG (0.38 ± 0.42). There were no recorded exposures to P80. Conclusions: Inflammatory bowel disease participants were exposed to more emulsifiers than HCs. Intake of inflammatory emulsifiers were low or nonexistent, suggesting their presence in the food supply are not as common as frequently stated. � 2024 The Author(s). | - |
dc.publisher | Oxford University Press | - |
dc.subject | Crohn's disease diet emulsifier food additive inflammatory bowel disease nutrition observational study ulcerative colitis Adolescent Adult Aged Australia Carboxymethylcellulose Sodium Case-Control Studies Child Colitis, Ulcerative Crohn Disease Dietary Exposure Emulsifying Agents Female Humans Inflammatory Bowel Diseases Lecithins Male Middle Aged Polysaccharides, Bacterial Polysorbates Prospective Studies Young Adult carboxymethylcellulose carrageenan diacylglycerol emulsifying agent phosphatidylcholine polysorbate 80 xanthan bacterial polysaccharide polysorbate Article body mass cohort analysis dietary intake human inflammation major clinical study microbiome adverse event case control study epidemiology prospective study | - |
dc.title | Dietary Emulsifier Exposure in People with Inflammatory Bowel Disease Compared with Healthy Controls: Is There a Cause for Concern? | - |
dc.type | Journal Article | - |
dc.contributor.swslhdauthor | Williams, Astrid-Jane | - |
dc.contributor.swslhdauthor | Connor, Susan J. | - |
dc.description.affiliates | School of Medical, Indigenous and Health Science, University of Wollongong, NSW, Australia Microbiome Research Centre, University of New South Wales, Kogarah, NSW, Australia St Vincent's Hospital, Department of Gastroenterology and Hepatology, Sydney, NSW, Australia Department of Paediatrics, School of Clinical Medicine, University of New South Wales, Sydney, NSW, Australia Liverpool Hospital Dept of Gastroenterology and Hepatology, Liverpool, NSW, Australia Ingham Institute for Applied Medical Research, Liverpool, NSW, Australia South West Sydney Clinical Campuses, University of New South Wales Medicine and Health, University of New South Wales, Sydney, Australia Centre for Gastrointestinal Health Castle Hill, NSW, Australia Garvan Institute of Medical Research, School of Clinical Medicine, St Vincent's Healthcare Clinical Campus, University of New South Wales Medicine and Health, University of New South Wales, Sydney, Australia | - |
dc.identifier.doi | 10.1093/ibd/izad318 | - |
dc.identifier.department | Liverpool Hospital, Department of Gastroenterology and Hepatology | - |
dc.type.studyortrial | Article | - |
dc.identifier.journaltitle | Inflammatory Bowel Diseases | - |
Appears in Collections: | Liverpool Hospital |
Files in This Item:
There are no files associated with this item.
Items in Prosentient are protected by copyright, with all rights reserved, unless otherwise indicated.